Oxiracetam
Top View
- Alternations of NMDA and GABAB Receptor Function in Development: a Potential Animal Model of Schizophrenia
- Cocaine, Nicotine, and Their Conditioned Contexts Enhance Consolidation of Object Memory in Rats
- Practice Parameter: Management of Dementia (An Evidence-Based Review)
- Nootropics Use in the Workplace: Psychiatric and Ethical Aftermath Towards the New Frontier of Bioengineering
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Drugs Affecting the Central Nervous System
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- Pharmacology and Toxicology
- Nootropics for Better Judgment
- Psicotrópicos Y Estupefacientes Visión Farmacológica Y Normativa
- (12) Patent Application Publication (10) Pub. No.: US 2014/0349976 A1 HACKSELL Et Al
- (12) United States Patent (10) Patent No.: US 9,358,295 B2 Tygesen Et Al
- 2-Pyrrolidinone Moiety Is Not Critical for the Cognition-Enhancing Activity of Piracetam-Like Drugs
- Substance Abuse in the Workplaces of Our Bodies and Mind
- Facilitating Effect of Oxiracetam and Piracetam on Acquisition of Discrete Two-Way Shuttle Avoidance in Normal Mice
- Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
- Racetam Cheatsheet
- Harmonized Tariff Schedule of the United States (2006) (Rev